BDNF and depressive symptom measurement: The enhanced expression of BDNF, p-ERK1/2 and p-CREB in the hippocampus of mice suffering from alcohol-induced cognitive decline and depression demonstrated the efficacy and potential of high-dose HME treatment as a preventive and therapeutic medicine for ARD.